Maternal RSV Vaccine — Weighing Benefits and Risks

Overview of attention for article published in New England Journal of Medicine, March 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

news: 9 news outlets
blogs: 1 blog
policy: 1 policy source

twitter: 24 X users
facebook: 1 Facebook page

Readers on

mendeley: 20 Mendeley

So far, Altmetric has seen 25 X posts from 24 X users, with an upper bound of 1,717,916 followers.

según un editorial del New England Journal of Medicine escrito por la Dra. Sonja A. Rasmussen y Denise J. Jamieson. https://t.co/HvTgd4g6BX

What drives me nuts is that the NEJM editorial was written by authors with COIs. Of course they stated than preterm risks were small compared to the proven benefits.... https://t.co/qStOVlWQ28

RT @NEJM: Editorial: Maternal RSV Vaccine — Weighing Benefits and Risks https://t.co/wu8NEPLEyE

RT @NEJM: Original Article: RSV Prefusion F Protein–Based Maternal Vaccine — Preterm Birth and Other Outcomes https://t.co/k3ZyTTGnyD Edi…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 21 additional X posts.